Wnt/β-Catenin Pathway-Mediated <i>PD-L1</i> Overexpression Facilitates the Resistance of Non-Small Cell Lung Cancer Cells to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

For Authors|For Editors|For Reviewers

Wnt/β-Catenin Pathway-Mediated PD-L1 Overexpression Facilitates the Resistance of Non-Small Cell Lung Cancer Cells to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Zhangdan Huang, Jianjun Wang, Zehai Xia, Qun Lv, Zhaoyang Ruan, Yifan Dai

Discovery Medicine . 2024, (190): 2300 -2308 . DOI: 10.24976/Discov.Med.202436190.211

About Discovery Medicine
Editorial Board
Article Processing Charge
Submit

For Authors
For Editors
For Reviewers

Open Access Statement
Copyright & License
Digital Archive

Latest Issue
All Issues
Special Issues

By using this website, you agree to our Terms & Conditions and Privacy Policy.

Disclaimer

The statements, opinions and data contained in Discovery Medicine are solely those of the individual authors and contributors and not of the journal and the editor(s). Discovery Medicine stays neutral with regard to jurisdictional claims in published maps and insitutional affiliations.